Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 2
2011 4
2012 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.
Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. Kota J, et al. Cell. 2009 Jun 12;137(6):1005-17. doi: 10.1016/j.cell.2009.04.021. Cell. 2009. PMID: 19524505 Free PMC article.
Novel therapeutic strategies for targeting liver cancer stem cells.
Oishi N, Wang XW. Oishi N, et al. Int J Biol Sci. 2011 Apr 26;7(5):517-35. doi: 10.7150/ijbs.7.517. Int J Biol Sci. 2011. PMID: 21552419 Free PMC article. Review.
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG, Tan TM. Li Y, et al. Cancer Sci. 2009 Jul;100(7):1234-42. doi: 10.1111/j.1349-7006.2009.01164.x. Epub 2009 Apr 15. Cancer Sci. 2009. PMID: 19486339 Free article.
Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, Run W, Tian L, Jia X, Gao Y. Gui J, et al. Clin Sci (Lond). 2011 Mar;120(5):183-93. doi: 10.1042/CS20100297. Clin Sci (Lond). 2011. PMID: 20815808 Free PMC article.
Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development.
Yip WK, Cheng AS, Zhu R, Lung RW, Tsang DP, Lau SS, Chen Y, Sung JG, Lai PB, Ng EK, Yu J, Wong N, To KF, Wong VW, Sung JJ, Chan HL. Yip WK, et al. PLoS One. 2011;6(8):e22888. doi: 10.1371/journal.pone.0022888. Epub 2011 Aug 4. PLoS One. 2011. PMID: 21829663 Free PMC article.
Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, Suzuki Y, Aoki T, Murakami Y, Toyoda H, Kumada T, Bartenschlager R, Kato N, Ikeda M, Takashina T, Tanaka M, Suzuki R, Oikawa K, Takanashi M, Kuroda M. Shigoka M, et al. Pathol Int. 2010 May;60(5):351-7. doi: 10.1111/j.1440-1827.2010.02526.x. Pathol Int. 2010. PMID: 20518884
MicroRNA expression, survival, and response to interferon in liver cancer.
Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW. Ji J, et al. N Engl J Med. 2009 Oct 8;361(15):1437-47. doi: 10.1056/NEJMoa0901282. N Engl J Med. 2009. PMID: 19812400 Free PMC article.
Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K. Li LM, et al. Cancer Res. 2010 Dec 1;70(23):9798-807. doi: 10.1158/0008-5472.CAN-10-1001. Epub 2010 Nov 23. Cancer Res. 2010. PMID: 21098710 Free article.
Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Wang LG, Gu J. Wang LG, et al. Cancer Epidemiol. 2012 Feb;36(1):e61-7. doi: 10.1016/j.canep.2011.05.002. Epub 2011 Oct 21. Cancer Epidemiol. 2012. PMID: 22018950
Feedback